Jove
Visualize
Contact Us

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovative integration of high dose ketamine infusion, psychological services, and specialized multidisciplinary pain care for refractory pain syndromes.

Pain management·2026
Same author

Little red dots as young supermassive black holes in dense ionized cocoons.

Nature·2026
Same author

Risk and protective factors for suicide-related outcomes among serving military personnel: a systematic review of cohort studies.

BMJ military health·2025
Same author

The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.

International journal of cardiology·2024
Same author

Capnodynamic monitoring of lung volume and pulmonary blood flow during alveolar recruitment: a prospective observational study in postoperative cardiac patients.

Journal of clinical monitoring and computing·2023
Same author

Bypassing the post-anaesthesia care unit after elective hip and knee arthroplasty.

Anaesthesia·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 11, 2026

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
07:32

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

Published on: February 7, 2018

Balsalazide-induced myocarditis.

E Robertson, D Austin, N Jamieson

    International Journal of Cardiology
    |September 25, 2007
    PubMed
    Summary

    Balsalazide, a medication for ulcerative colitis, can cause drug-induced myocarditis, a heart inflammation. Stopping the medication led to the patient's full recovery and resolution of cardiac abnormalities.

    Area of Science:

    • Cardiology
    • Gastroenterology
    • Pharmacology

    Background:

    • Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
    • Balsalazide is a common treatment for UC, delivering 5-aminosalicylic acid to the colon.
    • Adverse cardiovascular events are rare but serious side effects of medications.

    Observation:

    • A 38-year-old male with UC presented with chest pain.
    • Recent initiation of balsalazide therapy for UC.
    • Clinical presentation included myocardial necrosis, ECG changes, and echocardiographic wall motion abnormalities.

    Findings:

    • Coronary angiography revealed normal epicardial coronary arteries.
    • Cardiac MRI excluded left ventricular (LV) scar.
    • Diagnosis of drug-induced myocarditis attributed to balsalazide.

    Related Experiment Videos

    Last Updated: Jul 11, 2026

    Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
    07:32

    Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

    Published on: February 7, 2018

  • Discontinuation of balsalazide led to complete clinical recovery.

    • Implications:

    • This case highlights balsalazide as a potential cause of drug-induced myocarditis.
    • Early recognition and withdrawal of the offending agent are crucial for patient outcomes.
    • Clinicians should consider medication side effects in patients with unexplained cardiac symptoms.